|
Size: 699
Comment:
|
Size: 1362
Comment:
|
| Deletions are marked like this. | Additions are marked like this. |
| Line 2: | Line 2: |
| == Association Analysis for Rare Variants == * '''Statistical analysis strategies for association studies involving rare variants.'''<<BR>> Bansal V, Libiger O, Torkamani A, Schork NJ.<<BR>> Nat Rev Genet. 2010 Nov;11(11):773-85. Epub 2010 Oct 13. Review.<<BR>> PMID: 20940738 * '''An evaluation of statistical approaches to rare variant analysis in genetic association studies.'''<<BR>> Morris AP, Zeggini E.<<BR>> Genet Epidemiol. 2010 Feb;34(2):188-93.<<BR>> PMID: 19810025 == Gene-set Association Tests for Rare Variants == |
|
| Line 3: | Line 13: |
| * Patient-oriented gene set analysis for cancer mutation data. Boca SM, Kinzler K, Velculescu VE, Vogelstein B, Parmigiani G. Genome Biol. 2010 Nov 23;11(11):R112. |
== Similar Gene-set Analysis Strategies for Genetics Data == === Cancer Mutations === * '''Patient-oriented gene set analysis for cancer mutation data'''<<BR>> Boca SM, Kinzler K, Velculescu VE, Vogelstein B, Parmigiani G.<<BR>> Genome Biol. 2010 Nov 23;11(11):R112.<<BR>> |
| Line 7: | Line 19: |
| * It's basically the same idea applied to cancer instead of autism. * However, lacking the control patients (since cancer is high mutation frequency, that would not make sense), they have to define the null hypothesis using randomly placed mutations. * What they call "exclusivity principle" is what I usually call the "OR combination logic" (i.e. at least one perturbed gene for the pathway/gene-set to be perturbed). |
* It's basically the same idea applied to cancer instead of autism. * However, lacking the control patients (since cancer is high mutation frequency, that would not make sense), they have to define the null hypothesis using randomly placed mutations. * What they call "exclusivity principle" is what I usually call the "OR combination logic" (i.e. at least one perturbed gene for the pathway/gene-set to be perturbed). |
Association Analysis for Rare Variants
Statistical analysis strategies for association studies involving rare variants.
Bansal V, Libiger O, Torkamani A, Schork NJ.
Nat Rev Genet. 2010 Nov;11(11):773-85. Epub 2010 Oct 13. Review.
PMID: 20940738An evaluation of statistical approaches to rare variant analysis in genetic association studies.
Morris AP, Zeggini E.
Genet Epidemiol. 2010 Feb;34(2):188-93.
PMID: 19810025
Gene-set Association Tests for Rare Variants
Similar Gene-set Analysis Strategies for Genetics Data
Cancer Mutations
Patient-oriented gene set analysis for cancer mutation data
Boca SM, Kinzler K, Velculescu VE, Vogelstein B, Parmigiani G.
Genome Biol. 2010 Nov 23;11(11):R112.
http://www.ncbi.nlm.nih.gov/sites/entrez/21092299- It's basically the same idea applied to cancer instead of autism.
- However, lacking the control patients (since cancer is high mutation frequency, that would not make sense), they have to define the null hypothesis using randomly placed mutations.
- What they call "exclusivity principle" is what I usually call the "OR combination logic" (i.e. at least one perturbed gene for the pathway/gene-set to be perturbed).